JNJ vs LII · P/E 17, rev $49.37B vs P/E 27, rev $1.20B
Johnson & Johnson (JNJ) versus Lennox International Inc (LII) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Lennox International Inc (LII) is a building products & equipment company listed on US.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported LII revenue for 2025-12-31 was $1.20B. Net income was $142.5M. Revenue was down 77.6% from 2024-12-31 to 2025-12-31. LII currently screens at market cap $21.44B and trailing P/E 26.9.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. LII currently screens at market cap $21.44B and trailing P/E 26.9.
Not investment advice. Open the JNJ and LII stock pages for the full models.
Not investment advice.